Skip to content

Merck & Co. MRK PEG ratio

PEG ratio at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
0.5×
Johnson & Johnson logo
Johnson & JohnsonJNJ
0.2×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
8.6×+7.1×
United Therapeutics logo
United TherapeuticsUTHR
3.2×+2.4×
Amgen logo
AmgenAMGN
0.8×+0.3×
Abbott logo
AbbottABT
0.1×-2.8×

Other financials

Income statement

See full
Revenue$16.3B+4.9%
Gross profit$12.1B-0.2%
Net income-$4.2B-183%
EPS (diluted)-$1.72-186%

Balance sheet

See full
Cash & equivalents$5.4B-38.2%
Total debt$49.1B+35.8%
Total equity$45.9B-5.1%
Total assets$128.69B+11.8%

Cash flow

See full
Operating cash flow$3.9B+56.7%
CapEx$991.0M-25.4%
Free cash flow$2.9B+150%

Valuation

See full
Market cap$281.24B+31.2%
Enterprise value$324.94B+34.2%
P/E31.5×+19.2×
P/S4.3×+0.9×

Profitability

See full
Gross margin73.9%-2.5pp
Net margin13.6%-13.7pp

Returns & leverage

See full
Return on equity19%-20.3pp
Debt / equity1.1×+0.3×
Current ratio1.3×-0.1×

Where this comes from

Calculated from Merck & Co.’s reported figures.

Based on the most recent quarter.

The official record: Merck & Co.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merck & Co.'s peg ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merck & Co.'s PEG ratio?
Merck & Co. (MRK) reported PEG ratio of 2.2× in Q4 2025.
What does PEG ratio mean?
The P/E ratio adjusted for how fast earnings are growing.
How do you interpret PEG ratio?
Around 1.0 is often cited as fairly valued for the growth on offer; below 1.0 can flag a growth bargain. Highly sensitive to the growth input and meaningless when growth is zero or negative.
How does PEG ratio compare across companies?
A rough cross-company growth-adjusted screen; treat as directional given its sensitivity to the (trailing) growth basis.